Northwest Bancshares, Inc. Astrazeneca PLC Transaction History

Northwest Bancshares, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $4,084 - $4,572	-66 Reduced 1.92%	3,380 $227,000
Q3 2023 Oct 27, 2023	SELL	$64.85 - $71.7 $64 - $71	-1 Reduced 0.03%	3,446 $233,000
Q2 2023 Jul 24, 2023	SELL	$69.91 - $75.81 $74,943 - $81,268	-1,072 Reduced 23.72%	3,447 $246,000
Q1 2023 May 10, 2023	SELL	$63.15 - $71.6 $12,377 - $14,033	-196 Reduced 4.16%	4,519 $313,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $5,908 - $7,677	-109 Reduced 2.26%	4,715 $319,000
Q3 2022 Nov 15, 2022	SELL	$53.02 - $135.75 $8,165 - $20,905	-154 Reduced 3.09%	4,824 $264,000
Q2 2022 Aug 16, 2022	SELL	$59.26 - $71.14 $26,963 - $32,368	-455 Reduced 8.37%	4,978 $329,000
Q1 2022 Apr 29, 2022	SELL	$55.72 - $67.12 $5,126 - $6,175	-92 Reduced 1.67%	5,433 $360,000
Q4 2021 Feb 09, 2022	SELL	$54.02 - $63.83 $20,203 - $23,872	-374 Reduced 6.34%	5,525 $322,000
Q3 2021 Oct 13, 2021	SELL	$55.56 - $60.79 $12,445 - $13,616	-224 Reduced 3.66%	5,899 $354,000
Q2 2021 Aug 06, 2021	BUY	$48.42 - $60.18 $3,922 - $4,874	81 Added 1.34%	6,123 $367,000
Q1 2021 Apr 23, 2021	SELL	$47.16 - $54.44 $7,026 - $8,111	-149 Reduced 2.41%	6,042 $300,000
Q4 2020 Feb 05, 2021	BUY	$48.52 - $58.02 $15,817 - $18,914	326 Added 5.56%	6,191 $309,000
Q3 2020 Oct 20, 2020	SELL	$53.07 - $61.1 $54,449 - $62,688	-1,026 Reduced 14.89%	5,865 $321,000
Q2 2020 Aug 07, 2020	BUY	$43.1 - $55.31 $297,002 - $381,141	6,891 New	6,891 $364,000

1,335

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Northwest Bancshares, Inc., based on Form 13F filings with the SEC.

Stay updated on Northwest Bancshares, Inc. with notifications on news.